Science 37 to Present at the Cowen 43rd Annual Health Care Conference

Rhea-AI Summary

Science 37 Holdings, Inc. (Nasdaq: SNCE) will present at the Cowen 43rd Annual Health Care Conference in Boston on March 8, 2023, at 9:10 a.m. ET. The presentation will be accessible live and archived on the company's investor relations website.

Science 37 is a leader in accelerating clinical research through its unique Metasite™, allowing universal access for patients. This innovative model expands patient recruitment capabilities while ensuring diversity, enabling participation from home or local providers. The company is committed to delivering high-quality data using advanced technology and in-house expertise.

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming Cowen 43rd Annual Health Care Conference in Boston.

Science 37’s management is scheduled to present on Wednesday, March 8, 2023 at 9:10 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the investor relations section of the company’s website at: https://investors.science37.com.

About Science 37

Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite™ Science 37 reaches an expanded patient population beyond the traditional site and delivers the recruiting power of up to 20 sites in one with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own home, at their local community provider, or at a traditional site when needed. The Science 37 Metasite is powered by a proprietary technology platform, in addition to in-house investigators, mobile nurses, and remote coordinators that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.

Contacts:

MEDIA INQUIRIES:
Grazia Mohren
Science 37
Email: pr@science37.com

INVESTOR RELATIONS:
Steve Halper
LifeSci Advisors
Email: shalper@lifesciadvisors.com

FAQ

What is Science 37's participation at the Cowen 43rd Annual Health Care Conference?

Science 37 Holdings, Inc. will present at the Cowen 43rd Annual Health Care Conference in Boston on March 8, 2023, at 9:10 a.m. ET.

How can I access Science 37's presentation at the Cowen Conference?

You can access a live and archived webcast of Science 37's presentation on their investor relations website.

What is the Metasite™ of Science 37?

Science 37's Metasite™ is designed to enhance clinical research access, allowing patients to participate from home or local healthcare providers.

What are the benefits of Science 37's approach to clinical trials?

Science 37's approach increases patient diversity and flexibility while driving high-quality data and compliance.

What technology does Science 37 use for clinical trials?

Science 37 uses a proprietary technology platform, along with in-house investigators and remote coordinators, to facilitate clinical trials.